Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 20 (PPIAP20)

Target
PPIAP20
Molecular classification
Pseudogene, Long non-coding RNA family
01

Overview

Peptidylprolyl isomerase A pseudogene 20 (PPIAP20) is a non-protein-coding pseudogene homologous to the gene encoding cyclophilin A (PPIA), an enzyme with peptidyl-prolyl cis-trans isomerase activity that is involved in protein folding, signal transduction, immune regulation, and viral replication[1][7]. Unlike the parent gene, PPIAP20 does not encode a functional protein and is not considered a conventional pharmacological or therapeutic target. Although some pseudogenes can have regulatory functions at the RNA level—such as acting as microRNA sponges or competitive endogenous RNAs, as shown for PPIAP22[4]—there is no evidence that PPIAP20 directly impacts disease mechanisms or is targeted by drugs. PPIAP20 is catalogued in gene/nucleotide databases (e.g., NCBI Gene ID: 100500737), but there is little information about its functional roles or clinical significance[3]. Key distinctions: - This gene should not be confused with its parent gene, PPIA (cyclophilin A), which encodes a widely-studied enzyme implicated in inflammation, infection, cell cycle, and is the target of immunosuppressive drug cyclosporine A[1][5][7]. - Pseudogenes like PPIAP20 may have roles as non-coding RNAs in gene regulation, but current knowledge does not support a clinical or therapeutic role for PPIAP20 itself[4].

Other names
peptidylprolyl isomerase A (cyclophilin A) pseudogene 20PPIAP20

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 20 (PPIAP20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 20 (PPIAP20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call